On March 14, 2023, we announced that we do not expect to consummate an initial business combination before our mandatory liquidation date of March 25, 2023. Due to our inability to consummate an initial business combination within the time period required by our amended and restated memorandum and articles of association, we are redeeming our public shares in accordance with the provisions of our amended and restated articles memorandum and articles of association. There will be no redemption rights or liquidating distributions with respect to our warrants, which will expire worthless.
Results of Operations and Known Trends or Future Events
For the year ended December 31, 2022, we had net income of $11,966,686, which included income from the change in fair value of the warrant liability of $8,846,817, and Interest earned on investments held in Trust Account of $3,913,657, partially offset by loss from operations of $793,791.
For the period from January 27, 2021 (inception) through December 31, 2021, we had a net operating income of approximately $7.15 million, which included a gain from the change in fair value of the warrant liability of approximately $8.4 million and interest income on cash and investments held in Trust Account of $13,476 partially offset by loss from operations of $667,282 and offering cost expense allocated to warrants of $561,706.
Our business activities from inception to December 31, 2022 consisted primarily of our formation and completing our initial public offering (“Initial Public Offering” or “IPO”), and since the offering, our activity has been limited to identifying and evaluating prospective acquisition targets for an initial business combination.
Liquidity, Capital Resources and Going Concern Consideration
As of December 31, 2022, we had cash outside our trust account of $30,420, and working capital of $770,057. All remaining cash was held in the trust account and is generally unavailable for our use, prior to an initial business combination or liquidation.
Our liquidity needs have been satisfied prior to the completion of the Initial Public Offering through a payment of $25,000 capital contribution from our sponsor to cover certain offering costs on behalf of us in exchange for the issuance of the founder shares to our sponsor and up to $300,000 in loans from our sponsor.
On March 25, 2021, we consummated our Initial Public Offering of 25,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share, $0.0001 par value per share and one-fourth of one redeemable warrant to purchase one Class A ordinary share. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to us of $250,000,000. We granted Citigroup Global Markets Inc., the underwriter in the Initial Public Offering (the “Underwriter”), a 45-day option to purchase up to 3,750,000 additional Units to cover over-allotments, if any. On March 26, 2021, the Underwriter partially exercised the over-allotment option to purchase an additional 1,700,000 units (the “Over-Allotment Units”), which purchase settled on March 30, 2021, generating gross proceeds of $17,000,000. Simultaneously with the closing of the exercise of the over-allotment option, the Company completed the private sale (the “Private Placement”) of an aggregate of 226,666 warrants (the “Private Placement Warrants”) to our sponsor at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds of $340,000, which was used to pay the underwriting discount of 2% of the over-allotment gross proceeds.
Transaction costs of the Initial Public Offering (including the partial exercise of the underwriter’s over-allotment option) amounted to $15,188,496 consisting of $5,340,000 of underwriting discount, $9,345,000 of deferred underwriting discount, and $503,496 of other offering costs.
Upon closing of the Initial Public Offering, the Private Placement, and the sale of the Over-Allotment Units, a total of $267.0 million ($10.00 per Unit) was placed in a U.S.-based trust account, with Continental Stock Transfer & Trust Company acting as trustee. The proceeds held in the trust account have been invested only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.
24